Neurxstem, Inc is an avant-garde company based in Columbus, OH, that has developed a groundbreaking Neural Organoid Platform, which mimics the human central nervous system. Their platform is aimed at studying human brain disease mechanisms, creating early diagnostic tests, and facilitating drug discovery, efficacy, and safety testing.
With a focus on advancing human brain health through bold innovation, Neurxstem's patented synthetic Neural Organoid Platform has garnered attention from national and international press, as well as accolades from the scientific community. Their transformative approach has the potential to revolutionize the understanding and treatment of brain diseases such as cancer, autism, Parkinson's, and Alzheimer's.
Generated from the website